Attorney General Greg Zoeller entered into a settlement deal with Pfizer Inc. and 32 other attorneys general to resolve allegations that the company unlawfully promoted its drugs, Zyvox and Lyrica.

Zoeller said pharmaceutical companies can only promote a drug for the uses approved by the U.S. Food and Drug Administration, but doctors are free to prescribe the drug for other uses.

According to the complaint, Pfizer promoted Lyrica for off-label uses and used misleading and unsubstantiated superiority claims regarding Zyvox.

“Off-label marketing can put patients unnecessarily at risk. Pharmaceutical companies are required to only promote a prescription drug for uses that have been approved by the FDA,” Zoeller said.

As part of the settlement, Pfizer agreed to reform how it markets its drugs and promotes Zyvox and Lyrica .

Other states participating in the settlement are Alabama, Arizona, Arkansas, California, Colorado, Delaware, the District of Columbia, Florida, Hawaii, Idaho, Illinois, Kansas, Kentucky, Maryland, Michigan, Montana, Nebraska, Nevada, New Jersey, New Mexico, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Washington, Virginia, and Wisconsin.